Premium Selection ICAV - Polar Capital Future Healthcare Class Kh Fonds
97,10
CHF
-1,24
CHF
-1,26
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 8,86% |
| Zealand Pharma AS | DK0060257814 | 8,66% |
| Swedish Orphan Biovitrum AB | SE0000872095 | 8,35% |
| argenx SE | NL0010832176 | 6,02% |
| Hikma Pharmaceuticals PLC | GB00B0LCW083 | 4,87% |
| Chemed Corp | US16359R1032 | 4,77% |
| Xenon Pharmaceuticals Inc | CA98420N1050 | 4,76% |
| Intuitive Surgical Inc | US46120E6023 | 4,50% |
| Sandoz Group AG Registered Shares | CH1243598427 | 4,17% |
| Innovent Biologics Inc | KYG4818G1010 | 3,87% |
| Sonstige | 41,17% |